Paper3280680
Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.
Espevik T and 3 others. J Immunol, 1988. Cited by 181 papers, by iCite.
Cite this record
ConductScience Library. Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1. Papers, record 3280680. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3280680
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adjuvants, Immunologic | Major topic |
| Cytotoxicity, Immunologic | Major topic |
| Interleukin-2 | Major topic |
| Killer Cells, Natural | Major topic |
| Lymphocyte Activation | Major topic |
| Peptides | Major topic |
| Tumor Necrosis Factor-alpha | Major topic |
| Animals | |
| Biological Products | |
| Blood Platelets | |
| Cytokines | |
| Drug Synergism | |
| Humans | |
| Immunosuppressive Agents | |
| Recombinant Proteins | |
| Swine | |
| Transforming Growth Factors |
Source PubMed
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 181 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24376448 | Regulation of mouse NK cell development and function by cytokines. | Front Immunol | 2013 | https://conductscience.org/library/papers/24376448 | PubMed |
| 20107535 | Production of TGF-beta1 as a Mechanism for Defective Antigen-presenting Cell Function of Macrophages Generated in vitro with M-CSF. | Immune Netw | 2009 | https://conductscience.org/library/papers/20107535 | PubMed |
| 18363995 | Immunotherapy of malignant brain tumors. | Immunol Rev | 2008 | https://conductscience.org/library/papers/18363995 | PubMed |
| 11506504 | Enhanced VEGF production and decreased immunogenicity induced by TGF-beta 1 promote liver metastasis of pancreatic cancer. | Br J Cancer | 2001 | https://conductscience.org/library/papers/11506504 | PubMed |
| 10712667 | An acidic microenvironment impairs the generation of non-major histocompatibility complex-restricted killer cells. | Immunology | 2000 | https://conductscience.org/library/papers/10712667 | PubMed |
| 9821108 | Down-regulation of transforming growth factor-beta and interleukin-10 secretion from malignant glioma cells by cytokines and anticancer drugs. | J Neurooncol | 1998 | https://conductscience.org/library/papers/9821108 | PubMed |
| 9418859 | Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity. | Mol Cell Biol | 1998 | https://conductscience.org/library/papers/9418859 | PubMed |
| 9301535 | Changes in swine macrophage phenotype after infection with African swine fever virus: cytokine production and responsiveness to interferon-gamma and lipopolysaccharide. | Immunology | 1997 | https://conductscience.org/library/papers/9301535 | PubMed |
| 9301523 | Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells. | Immunology | 1997 | https://conductscience.org/library/papers/9301523 | PubMed |
| 9195490 | Effect of irradiation on transforming growth factor-beta secretion by malignant glioma cells. | J Neurooncol | 1997 | https://conductscience.org/library/papers/9195490 | PubMed |
| 9108081 | In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9108081 | PubMed |
| 8622912 | Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8622912 | PubMed |
| 8500113 | Factors, including transforming growth factor beta, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells. | Cancer Immunol Immunother | 1993 | https://conductscience.org/library/papers/8500113 | PubMed |
| 8406573 | Transforming growth factor-beta 1 enhances the generation of allospecific cytotoxic T lymphocytes. | Immunology | 1993 | https://conductscience.org/library/papers/8406573 | PubMed |
| 8391546 | Transforming growth factor-beta (TGF beta) inhibition of Epstein-Barr virus (EBV)- and interleukin-4 (IL-4)-induced immunoglobulin production in human B lymphocytes. | J Clin Immunol | 1993 | https://conductscience.org/library/papers/8391546 | PubMed |
| 8381531 | Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8381531 | PubMed |
| 8380285 | Effect of anti-CD3/anti-CD28/interleukin-2 stimulation of mononuclear cells on transforming growth factor beta inhibition of lymphokine-activated killer cell generation. | J Cancer Res Clin Oncol | 1993 | https://conductscience.org/library/papers/8380285 | PubMed |
| 8088926 | Interferon-alpha inhibits murine macrophage transforming growth factor-beta mRNA expression. | Inflammation | 1994 | https://conductscience.org/library/papers/8088926 | PubMed |
| 7961125 | Inhibition of tumor necrosis factor-alpha and -beta secretion by lymphokine activated killer cells by transforming growth factor-beta. | Jpn J Cancer Res | 1994 | https://conductscience.org/library/papers/7961125 | PubMed |
| 7944661 | Gene transfer for transplantation. Prolongation of allograft survival with transforming growth factor-beta 1. | Ann Surg | 1994 | https://conductscience.org/library/papers/7944661 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| LTA | 4049 | PubTator's text mining | https://conductscience.org/library/genes/4049 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| TGFB2 | 7042 | PubTator's text mining | https://conductscience.org/library/genes/7042 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3280680
GET https://conductscience.org/api/papers/v1/3280680/cited_by?page=2